Abstract
Lesions of the semilunar valve and the aortic arch can occur either in isolation or as part of well-described clinical syndromes. The polygenic cause of calcific aortic valve disease will be discussed including the key role of NOTCH1 mutations. In addition, the complex trait of bicuspid aortic valve disease will be outlined, both in sporadic/familial cases and in the context of associated syndromes, such as Alagille, Williams–Beuren, and Kabuki syndromes. Aortic arch abnormalities particularly coarctation of the aorta and interrupted aortic arch, including their association with syndromes such as Turner and 22q11 deletion, respectively, are also discussed. Finally, the genetic basis of congenital pulmonary valve stenosis is summarized, with particular note to Ras-/mitogen-activated protein kinase (Ras/MAPK) pathway syndromes and other less common associations, such as Holt–Oram syndrome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Armstrong EJ, Bischoff J (2004) Heart valve development: endothelial cell signaling and differentiation. Circ Res 95:459–470
Garg V (2006) Molecular genetics of aortic valve disease. Curr Opin Cardiol 21:180–184
Bella JN, Tang W, Kraja A et al (2007) Genome-wide linkage mapping for valve calcification susceptibility loci in hypertensive sibships: the Hypertension Genetic Epidemiology Network Study. Hypertension 49:453–460
Probst V, Le Scouarnec S, Legendre A et al (2006) Familial aggregation of calcific aortic valve stenosis in the western part of France. Circulation 113:856–860
Otto CM (2002) Calcification of bicuspid aortic valves. Heart 88:321–322
Garg V, Muth AN, Ransom JF et al (2005) Mutations in NOTCH1 cause aortic valve disease. Nature 437:270–274
Niessen K, Karsan A (2008) Notch signaling in cardiac development. Circ Res 102:1169–1181
Mohamed SA, Aherrahrou Z, Liptau H et al (2006) Novel missense mutations (p. T596M and p. P1797H) in NOTCH1 in patients with bicuspid aortic valve. Biochem Biophys Res Commun 345:1460–1465
Merla G, Brunetti-Pierri N, Piccolo P et al (2012) Supravalvular aortic stenosis: elastin arteriopathy. Circ Cardiovasc Genet 5:692–696
Pober BR, Johnson M, Urban Z (2008) Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome. J Clin Invest 11:1606–1615
Urban Z, Zhang J, Davis EC et al (2001) Supravalvular aortic stenosis: genetic and molecular dissection of a complex mutation in the elastin gene. Hum Genet 109:512–520
Mitchell SC, Korones SB, Berendes HW (1971) Congenital heart disease in 56,109 births. Incidence and natural history. Circulation 43:323–332
Rosenthal E (2005) Coarctation of the aorta from fetus to adult: curable condition or lifelong disease process? Heart 91:1495–1502
Braverman AC, Guven H, Beardslee MA et al (2005) The bicuspid aortic valve. Curr Probl Cardiol 30:470–522
Prapa M, Ho SY (2012) Risk stratification in bicuspid aortic valve disease: still more work to do. Eur J Cardiothorac Surg 41:327–328
Ho VB, Bakalov VK, Cooley M et al (2004) Major vascular anomalies in Turner syndrome: prevalence and magnetic resonance angiographic features. Circulation 110:1694–1700
Bondy C, Bakalov VK, Cheng C et al (2013) Bicuspid aortic valve and aortic coarctation are linked to deletion of the X chromosome short arm in Turner syndrome. J Med Genet 50:662–665
Loffredo CA, Chokkalingam A, Sill AM et al (2004) Prevalence of congenital cardiovascular malformations among relatives of infants with hypoplastic left heart, coarctation of the aorta, and d-transposition of the great arteries. Am J Med Genet A 124A:225–230
Loscalzo ML, Goh DL, Loeys B et al (2007) Familial thoracic aortic dilation and bicommissural aortic valve: a prospective analysis of natural history and inheritance. Am J Med Genet A 143A:1960–1967
Kappetein AP, Gittenberger-de Groot AC, Zwinderman AH et al (1991) The neural crest as a possible pathogenetic factor in coarctation of the aorta and bicuspid aortic valve. J Thorac Cardiovasc Surg 102:830–836
Spinner NB, Colliton RP, Crosnier C et al (2001) Jagged1 mutations in alagille syndrome. Hum Mutat 17:18–33
Colliton RP, Bason L, Lu FM et al (2001) Mutation analysis of Jagged1 (JAG1) in Alagille syndrome patients. Hum Mutat 17:151–152
McElhinney DB, Krantz ID, Bason L et al (2002) Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation 106:2567–2574
Raas-Rothschild A, Shteyer E, Lerer I et al (2002) Jagged1 gene mutation for abdominal coarctation of the aorta in Alagille syndrome. Am J Med Genet A 112:75–78
Kamath BM, Spinner NB, Emerick KM et al (2004) Vascular anomalies in Alagille syndrome: a significant cause of morbidity and mortality. Circulation 109:1354–1358
Zimrin AB, Pepper MS, McMahon GA et al (1996) An antisense oligonucleotide to the notch ligand jagged enhances fibroblast growth factor-induced angiogenesis in vitro. J Biol Chem 271:32499–32502
Xue Y, Gao X, Lindsell CE et al (1999) Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 8:723–730
Hallidie-Smith KA, Karas S (1988) Cardiac anomalies in Williams-Beuren syndrome. Arch Dis Child 63:809–813
Sugayama SM, Moises RL, Wagenfur J et al (2003) Williams-Beuren syndrome: cardiovascular abnormalities in 20 patients diagnosed with fluorescence in situ hybridization. Arq Bras Cardiol 81:462–473
Hughes HE, Davies SJ (1994) Coarctation of the aorta in Kabuki syndrome. Arch Dis Child 70:512–514
Digilio MC, Marino B, Toscano A et al (2001) Congenital heart defects in Kabuki syndrome. Am J Med Genet A 100:269–274
Ng SB, Bigham AW, Buckingham KJ et al (2010) Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 42:790–793
Issaeva I, Zonis Y, Rozovskaia T et al (2007) Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth. Mol Cell Biol 27:1889–1903
Glaser S, Schaft J, Lubitz S et al (2006) Multiple epigenetic maintenance factors implicated by the loss of Mll2 in mouse development. Development 133:1423–1432
Biben C, Weber R, Kesteven S et al (2000) Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ Res 87:888–895
Schott JJ, Benson DW, Basson CT et al (1998) Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281:108–111
Benson DW, Silberbach GM, Kavanaugh-McHugh A et al (1999) Mutations in the cardiac transcription factor NKX2-5 affect diverse cardiac developmental pathways. J Clin Invest 104:1567–1573
McElhinney DB, Geiger E, Blinder J et al (2003) NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol 42:1650–1655
Majumdar R, Yagubyan M, Sarkar G et al (2006) Bicuspid aortic valve and ascending aortic aneurysm are not associated with germline or somatic homeobox NKX2-5 gene polymorphism in 19 patients. J Thorac Cardiovasc Surg 131:1301–1305
Gaussin V, Van de Putte T, Mishina Y et al (2002) Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc Natl Acad Sci U S A 99:2878–2883
Kim RY, Robertson EJ, Solloway MJ (2001) Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. Dev Biol 235:449–466
Galvin KM, Donovan MJ, Lynch CA et al (2000) A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet 24:171–174
Tan HL, Glen E, Topf A et al (2012) Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation. Hum Mutat 33:720–727
Zaidi S, Choi M, Wakimoto H et al (2013) De novo mutations in histone-modifying genes in congenital heart disease. Nature 498:220–223
Powell CB, Stone FM, Atkins DL et al (1997) Operative mortality and frequency of coexistent anomalies in interruption of the aortic arch. Am J Cardiol 79:1147–1148
Gruber PJ, Epstein JA (2004) Development gone awry: congenital heart disease. Circ Res 94:273–283
Corsten-Janssen N, Kerstjens-Frederikse WS, du Marchie Sarvaas GJ et al (2013) The cardiac phenotype in patients with a CHD7 mutation. Circ Cardiovasc Genet 6:248–254
Goldmuntz E, Clark BJ, Mitchell LE et al (1998) Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol 32:492–498
Ryan AK, Goodship JA, Wilson DI et al (1997) Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 34:798–804
Marino B, Digilio MC, Toscano A et al (2001) Anatomic patterns of conotruncal defects associated with deletion 22q11. Genet Med 3:45–48
Gao S, Li X, Amendt BA (2013) Understanding the role of Tbx1 as a candidate gene for 22q11.2 deletion syndrome. Curr Allergy Asthma Rep 13:613–621
Merscher S, Funke B, Epstein JA et al (2001) TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104:619–629
Marino B, Digilio MC, Persiani M et al (1999) Deletion 22q11 in patients with interrupted aortic arch. Am J Cardiol 84:360–361
Marino B, Digilio MC, Toscano A et al (1999) Congenital heart diseases in children with Noonan syndrome: an expanded cardiac spectrum with high prevalence of atrioventricular canal. J Pediatr 135:703–706
Roberts AE, Allanson JE, Tartaglia M et al (2013) Noonan syndrome. Lancet 381:333–342
Tartaglia M, Mehler EL, Goldberg R et al (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29:465–468
Tartaglia M, Kalidas K, Shaw A et al (2002) PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 70:1555–1563
Croonen EA, Nillesen W, Schrander C et al (2013) Noonan syndrome: comparing mutation-positive with mutation-negative dutch patients. Mol Syndromol 4:227–234
Lin AE, Alexander ME, Colan SD et al (2011) Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: a Ras/MAPK pathway syndrome. Am J Med Genet A 155A:486–507
Ben-Shachar S, Constantini S, Hallevi H et al (2013) Increased rate of missense/in-frame mutations in individuals with NF1-related pulmonary stenosis: a novel genotype-phenotype correlation. Eur J Hum Genet 21:535–539
Patel C, Silcock L, McMullan D et al (2012) TBX5 intragenic duplication: a family with an atypical Holt-Oram syndrome phenotype. Eur J Hum Genet 20:863–869
Xiang R, Fan LL, Huang H et al (2014) A novel mutation of GATA4 (K319E) is responsible for familial atrial septal defect and pulmonary valve stenosis. Gene 534:320–323
Garg V, Kathiriya IS, Barnes R et al (2003) GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424:443–447
Okubo A, Miyoshi O, Baba K et al (2004) A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family. J Med Genet 41:e97
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Wien
About this chapter
Cite this chapter
Prapa, M., Ho, S.Y. (2016). Human Genetics of Semilunar Valve and Aortic Arch Anomalies. In: Rickert-Sperling, S., Kelly, R., Driscoll, D. (eds) Congenital Heart Diseases: The Broken Heart. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1883-2_41
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1883-2_41
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1882-5
Online ISBN: 978-3-7091-1883-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)